It is well established that type 2 diabetes is associated with a range of macrovascular and microvascular complications. Nor is prediabetes a benign condition – for example, it carries a two- to three-fold increased risk of cardiovascular events. 1
Prediabetes and how to recognise the condition has been discussed in an earlier Independent Nursearticle.2
What interventions could interrupt the journey from normoglycaemia through prediabetes to type 2 diabetes? There are now a number of randomised controlled trials in a variety of populations and countries that focus on lifestyle and pharmacological interventions. The individuals in these trials typically had prediabetes defined by impaired glucose tolerance (or impaired fasting glucose) – that is, they were at high risk of developing diabetes.
Register now for access
Thank you for visiting Independent Nurse and reading some of our premium content. To read more, please register today.
Register
Already have an account? Sign in here